Barclays’s AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF SIXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.38K Buy
140
+37
+36% +$1.17K ﹤0.01% 4786
2025
Q4
$3.25K Sell
103
-1,115
-92% -$34.7K ﹤0.01% 5018
2025
Q3
$37.5K Sell
1,218
-3,806
-76% -$114K ﹤0.01% 4836
2025
Q2
$147K Sell
5,024
-160
-3% -$4.46K ﹤0.01% 4466
2025
Q1
$143K Buy
+5,184
New +$145K ﹤0.01% 4251

Other funds holding SIXP

Barclays's SIXP Position: Q1 2026 in Review

Barclays increased its AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF (SIXP) stake by 36% in Q1 2026, buying an estimated $1.17K and bringing the position to 140 shares worth $4.38K. The position accounts for ﹤0.01% of the portfolio, ranked #4786.

Barclays first reported a position in SIXP in Q1 2025 and has held it in 5 quarters since. The position peaked at $147K in Q2 2025. 31 funds tracked by Wall St. Rank hold SIXP as of Q1 2026.

  • Barclays held 140 shares of AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF worth $4.38K as of Q1 2026.
  • Barclays bought 37 AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF shares in Q1 2026, an estimated $1.17K.
  • AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4786 holding.
  • Barclays first reported a position in AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF in Q1 2025 and has held it in 5 quarters since.
  • Barclays's AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF position peaked at $147K in Q2 2025.
  • 31 funds tracked by Wall St. Rank held AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.